Substance / Medication

Dydrogesterone

Overview

Active Ingredient
dydrogesterone
RxNorm CUI
3706

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
A critical appraisal of safety data on dydrogesterone for the support of early pregnancy: a scoping review and meta-analysis.
Katalinic Alexander, Shulman Lee P, Strauss Jerome F et al. · Reprod Biomed Online · 2022
PMID: 35644880Meta-Analysis
The Effect of Letrozole Combined with Dydrogesterone for Endometriosis in China: A Meta-Analysis.
Sun Shumei, Zhang Hao, Zhong Peicheng et al. · Biomed Res Int · 2021
PMID: 34901283Meta-AnalysisFull text (PMC)
Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis.
Peng Chao, Huang Yan, Zhou Yingfang · Arch Gynecol Obstet · 2021
PMID: 33398505Meta-AnalysisFull text (PMC)
Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.
Barbosa Marina Wanderley Paes, Valadares Natália Paes Barbosa, Barbosa Antônio César Paes et al. · JBRA Assist Reprod · 2018
PMID: 29488367Meta-AnalysisFull text (PMC)
The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.
Lee Hee Joong, Park Tae Chul, Kim Jae Hoon et al. · Biomed Res Int · 2017
PMID: 29392134Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dydrogesterone (substance)
SNOMED CT
126093005
UMLS CUI
C0013340
RxNorm CUI
3706

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.